This Article  • References  • Full text PDF  • Correction  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Relationship to Thyroid Supplements for Hypothyroidism

Chandrakant C. Kapdi, MD; John N. Wolfe, MD

JAMA. 1976;236(10):1124-1127.

Abstract
This study was undertaken to determine the relationship between thyroid supplements and breast cancer. The incidence of breast cancer among the patients who received thyroid supplements was 12.13%, while in the control group it was 6.2%. The incidence rate of breast cancer was 10%, 9.42%, and 19.48% among patients who received thyroid supplements for one to five, 5 to 15, and for more than 15 years, respectively. The incidence of breast cancer among nulliparous women who received thyroid supplements was 33%, while in the nulliparous women without thyroid supplements the incidence was only 9.25%. Even in a specific age group, the incidence rate of breast cancer was higher among patients receiving thyroid supplements, when compared to the control patients in the same age group.

(JAMA 236:1124-1127, 1976)

Author Affiliations
From the Department of Radiology, Hutzel Hospital, Detroit.

Footnotes
Reprint requests to Department of Radiology, Hutzel Hospital, 432 E Hancock, Detroit, MI 48201 (Dr Kapdi).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Morbidity, Mortality, and Quality of Life for Patients Treated With Levothyroxine
Petersen et al.
Arch Intern Med 1990;150:2077-2081.
ABSTRACT  

The Aging Thyroid: The Use of Thyroid Hormone in Older Persons
Sawin et al.
JAMA 1989;261:2653-2655.
ABSTRACT  

Oral Thyroxine: Variation in Biologic Action and Tablet Content
SAWIN et al.
ANN INTERN MED 1984;100:641-645.
ABSTRACT  

Breast Cancer in Hypothyroid Women Using Thyroid Supplements
Hoffman et al.
JAMA 1984;251:616-619.
ABSTRACT  

Use of Thyroid Supplements in Relation to the Risk of Breast Cancer
Shapiro et al.
JAMA 1980;244:1685-1687.
ABSTRACT  

Detecting Unsuspected Thyroid Dysfunction by the Free Thyroxine Index
dos Remedios et al.
Arch Intern Med 1980;140:1045-1049.
ABSTRACT  

A Case-Control Study of Menopausal Estrogen Therapy and Breast Cancer
Ross et al.
JAMA 1980;243:1635-1639.
ABSTRACT  

The Thyroid, Prolactin, and Breast Cancer
VanderLaan and Larson
Arch Intern Med 1978;138:1611-1612.
ABSTRACT  

Thyroid-Stimulating Hormone and Prolactin Levels in Breast Cancer
Aldinger et al.
Arch Intern Med 1978;138:1638-1641.
ABSTRACT  

Incidence of Malignant Neoplasms of All Types in Patients With Graves' Disease
Munoz et al.
Arch Intern Med 1978;138:944-947.
ABSTRACT  

Thyroid Hormone Use in Patients With Breast Cancer: Absence of an Association
Wallace et al.
JAMA 1978;239:958-958.
ABSTRACT  

Thyroid Supplementation for Hypothyroidism: An latrogenic Cause of Breast Cancer?
Mustacchi and Greenspan
JAMA 1977;237:1446-1447.
ABSTRACT  

Breast Cancer and Thyroid Therapy: Statement by the American Thyroid Association
Gorman et al.
JAMA 1977;237:1459-1460.
ABSTRACT  

American Thyroid Association Statement: Breast Cancer and Thyroid Hormone Therapy
EDUCATION COMMITTEE et al.
ANN INTERN MED 1977;86:502-503.
ABSTRACT